Drug intelligence / Profile preview

Radio Salil

Development stage
Unknown
Lead developer
Laboratorios Viñas
Modality
Small Molecules
Administration
Topical
01

Overview

Radio Salil is a topical analgesic and rubefacient combination product developed and marketed by Laboratorios Viñas. It is indicated for the local symptomatic relief of muscle and joint pain, including conditions such as lumbago, torticollis, strains, and sprains. The formulation typically comprises methyl salicylate, menthol, salicylic acid, camphor, and methyl nicotinate. These components work through multiple mechanisms: methyl salicylate and salicylic acid inhibit cyclooxygenase enzymes to reduce prostaglandin-mediated inflammation and pain; menthol and camphor act as counter-irritants by stimulating thermal receptors (TRPM8 and TRPV1, respectively); and methyl nicotinate induces local vasodilation (rubefacient effect), which enhances blood flow to the affected area and promotes a warming sensation.

Brand names
Radio Salil
Other names
Radiosalil
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Radio Salil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radio Salil.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call